149 related articles for article (PubMed ID: 8232801)
1. Low-grade astrocytomas may arise from different astrocyte lineages.
Piepmeier JM; Fried I; Makuch R
Neurosurgery; 1993 Oct; 33(4):627-32. PubMed ID: 8232801
[TBL] [Abstract][Full Text] [Related]
2. A2B5 lineages of human astrocytic tumors and their recurrence.
Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
[TBL] [Abstract][Full Text] [Related]
3. Dual lineage of astrocytomas.
Bishop M; de la Monte SM
Am J Pathol; 1989 Sep; 135(3):517-27. PubMed ID: 2551172
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy.
Schramm J; Luyken C; Urbach H; Fimmers R; Blümcke I
Neurosurgery; 2004 Aug; 55(2):340-7; discussion 347-8. PubMed ID: 15271240
[TBL] [Abstract][Full Text] [Related]
6. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
[TBL] [Abstract][Full Text] [Related]
7. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
8. In vitro identification and functional characterization of glial precursor cells in human gliomas.
Colin C; Baeza N; Tong S; Bouvier C; Quilichini B; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2006 Apr; 32(2):189-202. PubMed ID: 16599947
[TBL] [Abstract][Full Text] [Related]
9. Antigenic staining patterns of human glioma cultures: primary cultures, long-term cultures and cell lines.
Westphal M; Nausch H; Herrmann HD
J Neurocytol; 1990 Aug; 19(4):466-77. PubMed ID: 2243242
[TBL] [Abstract][Full Text] [Related]
10. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
11. Supratentorial gliomas: a comparative study by grade and histologic type.
Shaw EG; Scheithauer BW; O'Fallon JR
J Neurooncol; 1997 Feb; 31(3):273-8. PubMed ID: 9049856
[TBL] [Abstract][Full Text] [Related]
12. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of GFAP-δ and nestin in cerebral astrocytomas.
Brehar FM; Arsene D; Brinduse LA; Gorgan MR
Brain Tumor Pathol; 2015 Apr; 32(2):90-8. PubMed ID: 25178519
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical quantitative study of glial fibrillary acid protein and vimentin of astrocytomas].
Xu QZ; Duan HL; Lu DH
Zhonghua Bing Li Xue Za Zhi; 1994 Apr; 23(2):66-8. PubMed ID: 8082240
[TBL] [Abstract][Full Text] [Related]
16. Uniform lineage of oligodendrogliomas.
de la Monte SM
Am J Pathol; 1989 Sep; 135(3):529-40. PubMed ID: 2675625
[TBL] [Abstract][Full Text] [Related]
17. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
[TBL] [Abstract][Full Text] [Related]
18. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of supratentorial astrocytoma WHO grade II.
Peraud A; Ansari H; Bise K; Reulen HJ
Acta Neurochir (Wien); 1998; 140(12):1213-22. PubMed ID: 9932120
[TBL] [Abstract][Full Text] [Related]
20. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]